The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) provides advice, information, and recommendations to the Secretary regarding programs and policies intended to support and evaluate the implementation of U.S. government activities related to combating antibiotic-resistant bacteria.
The PACCARB was established initially under Executive Order 13676, dated September 18, 2014. On March 3, 2020, the President of the United States delegated his authority to the Secretary of Health and Human Services under section 9(a)(1) of the Federal Advisory Committee Act (FACA), Public Law 92-463, as amended (5 U.S.C. App.), to re-establish the PACCARB. Pursuant to this delegation of authority, the Secretary is re-establishing the Advisory Council, and the charter was filed on September 2, 2020. Per the President's delegation of authority, the Secretary may direct the PACCARB to perform duties consistent with those assigned to them in section 505(b) of Public Law 116-22 (June 24, 2019), the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA).
The PACCARB may establish standing and ad hoc working groups to provide assistance for carrying out its function. PACCARB currently has three working groups exploring incentives for the development of products to address antibiotic-resistance.